Results 151 to 160 of about 8,379,611 (261)

Comparing Approaches for Estimating Counterfactual HIV Incidence Among Populations With High Vulnerability to HIV in Lima, Peru: A Multi‐Study Comparative Analysis

Journal of the International AIDS Society, Volume 29, Issue 9, September 2026.
ABSTRACT Introduction The availability of highly efficacious HIV pre‐exposure prophylaxis (PrEP) makes it unethical or infeasible to conduct inactive/placebo‐controlled trials to evaluate new HIV prevention options. As a result, randomized active‐control non‐inferiority trials are typically employed; however, they require large sample sizes and ...
Fei Gao, Sayan Dasgupta, Siavash Pasalar, Qi Wang, Ricardo Alfaro, Delia Pinto‐Santini, Thiago S. Torres, Jorge Sanchez, Javier R. Lama, Valdilea G. Veloso, Michal Juraska, Robinson Cabello, Jorge O. Alarcon, Beatriz Grinsztejn, Carlos F. Caceres, James F. Rooney, Ann Duerr   +16 more
wiley   +1 more source

The HIV Landscape for Transgender Women Living in Southwest Asia and North Africa: A Scoping Review

Journal of the International AIDS Society, Volume 29, Issue 9, September 2026.
ABSTRACT Introduction This scoping review aimed to characterize the prevalence and determinants of HIV acquisition among transgender women in Southwest Asia and North Africa (SWANA), to describe HIV preventive activities and measures, and to examine barriers to HIV and gender‐affirming care, including experiences of stigma, discrimination and mental ...
Ala Koreitem, Sasha Abdallah Fahme, Parya Saberi   +2 more
wiley   +1 more source

Real‐World Experience With Lenacapavir and/or Fostemsavir as Emerging Therapies for the Management of Multidrug‐Resistant HIV‐1 in Southeastern France

Journal of Medical Virology, Volume 98, Issue 9, September 2026.
ABSTRACT Lenacapavir and fostemsavir, two recently approved anti‐HIV‐1 agents, are promising options for people with difficult‐to‐treat HIV; however, real‐world data remain limited. This study aimed to describe the epidemiological, clinical, and virological profiles of people receiving combination antiretroviral regimens, including lenacapavir and/or ...
Syrine Boujamline, Celine Boschi, Hugo Bes‐Barlandier, Christelle Tomei, Amelie Menard, Saadia Mokhtari, Isabelle Ravaux, Yacine Belkhir, Nadege Neant, Caroline Solas, Philippe Colson, Matthieu Million   +11 more
wiley   +1 more source

Biological Depiction of Lipodystrophy and Its Associated Challenges Among HIV AIDS Patients: Literature Review

HIV/AIDS: Research and Palliative Care
Tolera Ambisa Lamesa School of Medical Laboratory Science, Jimma University, Jimma, EthiopiaCorrespondence: Tolera Ambisa Lamesa, Email toleraambisa@gmail.comAbstract: Lipodystrophy syndrome is a medical condition characterized by the absence of adipose ...
Lamesa TA
doaj  

Ocular Complications in Patients on Highly Active Antiretroviral Therapy: A Case Report. [PDF]

Cureus, 2023
Dash S, Mohanty SK, Mohanty G.
europepmc   +1 more source

Next‐Generation Pluronic Micelles for Advanced Drug Delivery Application

Macromolecular Materials and Engineering, Volume 311, Issue 9, September 2026.
The present review provides a comprehensive overview of Pluronic‐based micelles for advanced drug and gene delivery. It highlights their structure, classification, synthesis, self‐assembly, and functionalization, as well as their biocompatibility and stimuli‐responsive properties.
Manoj Gundeti, Nithin Vidiyala, Shreya Dalvi, Rushikesh Girase, Sunil kumar Thota, Keshav Raj Paudel, Sathish Dyawanapelly   +6 more
wiley   +1 more source

The Veterans Aging Cohort Study (VACS)‐National: A Real‐World Data Source Profile

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT The Veterans Aging Cohort Study (VACS)‐National is a large, longitudinal real‐world data resource derived from electronic health records within the Department of Veterans Affairs (VA), the largest integrated healthcare system in the United States. As of December 2025, VACS‐National includes > 14.9 million Veterans who have received care in the
Christopher T. Rentsch, Vincent Lo Re III, Melissa Skanderson, Kathleen A. McGinnis, Farah Kidwai‐Khan, Charles Alcorn, Anne C. Black, Kristina Crothers, Vincent C. Marconi, Matthew J. Freiberg, Jessie Torgersen, Amy C. Justice, William C. Becker, Lesley S. Park   +13 more
wiley   +1 more source

Semi‐Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 9, September 2026.
ABSTRACTSorfequiline is a novel diarylquinoline in development for treatment of tuberculosis. In vitro data suggest metabolism via CYP3A4, carrying the potential for presystemic metabolism and drug–drug interactions. Its major metabolite, M3, is pharmacologically active.
Jose M. Calderin, Jerry Nedelman, David H. Salinger, Thanakorn Vongjarudech, Paolo Denti, Elin M. Svensson   +5 more
wiley   +1 more source

HIV Risk Perception Among Migrant Girl Head Porters (Kayayei) in Ghana

Public Health Challenges, Volume 5, Issue 3, September 2026.
This study examines HIV/AIDS risk perception among migrant girl head porters (Kayayei) in Accra, Ghana. Although most perceive AIDS as dangerous and fear infection, cultural beliefs, economic pressures and structural barriers shape their responses. Findings highlight the need for culturally responsive HIV interventions that strengthen self‐efficacy and
Sylvester Kyei‐Gyamfi
wiley   +1 more source

Highly Active Antiretroviral Therapy [PDF]

, 2020
openaire   +1 more source